Back to search
FDAFDA · Food and drugs·Recall number D-0314-2015

MAYHEM capsules, Proprietary Blend 525 mg, Dietary Supplement, 60-count bottles, Chaotic-Labz, UPC 6 28586 67805 7.

Published December 31, 2014 · Recall initiated: November 14, 2014

Summary

FDA records drug Class II recall D-0314-2015, published December 31, 2014 and initiated November 14, 2014. Recalling firm: Chaotic Labz; Status: Terminated; Reported quantity: 990 bottles; Lot: Lot#: CLM061114, Exp 06/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared dexamethasone and cyproheptadine which are FDA approved drugs making this product an unapproved drug.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Chaotic Labz
Distributor
Nationwide.
Lot
Lot#: CLM061114, Exp 06/16
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was MAYHEM capsules, Proprietary Blend 525 mg, Dietary Supplement, 60-count bottles, Chaotic-Labz, UPC 6 28586 67805 7. recalled?

Yes. FDA published recall D-0314-2015 on December 31, 2014. Reported hazard: Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared dexamethasone and cyproheptadine which are FDA approved drugs making this product an unapproved drug.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release